| |
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549 |
OMB
APPROVAL |
| |
OMB
Number: 3235-0582 |
| |
Expires: July
31, 2024 |
| |
Estimated
average burden |
| |
hours
per response........4 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-
06565
Tekla World Healthcare Fund
(Exact name of registrant as specified in charter)
| 100
Federal Street, 19th Floor, Boston, MA |
|
02110 |
| (Address
of principal executive offices) |
|
(Zip
code) |
Laura Woodward
Tekla World Healthcare Fund
100
Federal Street, 19th Floor, Boston MA 02110
(Name and address of agent for service)
Registrant’s telephone number, including area code: 617-772-8500
Date
of fiscal year end: September 30
Date
of reporting period: 7/1/22-6/30/23
Form N-PX is to be used by a registered management
investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter),
to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record
for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4
thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review,
inspection, and policymaking roles.
A registrant is required to disclose the information
specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection
of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”)
control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for
reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has
reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
Vote Summary
1LIFE HEALTHCARE, INC.
| Security |
68269G107 |
Meeting Type |
Special |
| Ticker Symbol |
ONEM |
Meeting Date |
22-Sep-2022 |
| Record Date |
22-Aug-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To adopt the Agreement and Plan of Merger, dated July 20, 2022 (such agreement, as it may be amended,
modified or supplemented from time to time, the “Merger Agreement”), by and among 1Life Healthcare, Inc. (“1Life”),
a Delaware corporation, Amazon.com, Inc. (“Amazon”), a Delaware corporation, and Negroni Merger Sub, Inc. (“Merger
Sub”), a Delaware corporation. Upon the terms and subject to the conditions of the Merger Agreement, Amazon will acquire 1Life
via a merger of Merger Sub with and into 1Life, with 1Life continuing as the surviving corporation. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable
to 1Life’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated
by the Merger Agreement. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To adjourn the special meeting of the 1Life stockholders (the “Special Meeting”) to a later
date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement
if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. |
|
Management |
|
For |
|
For |
|
ABBOTT LABORATORIES
| Security |
002824100 |
Meeting Type |
Annual |
| Ticker Symbol |
ABT |
Meeting Date |
28-Apr-2023 |
| Record Date |
01-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: R. J. Alpern |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: C. Babineaux-Fontenot |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: S. E. Blount |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: R. B. Ford |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: P. Gonzalez |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: M. A. Kumbier |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: D. W. McDew |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: N. McKinstry |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: M. G. O’Grady |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: M. F. Roman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: D. J. Starks |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: J. G. Stratton |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Ernst & Young LLP As Auditors |
|
Management |
|
For |
|
For |
|
| 3. |
|
Say on Pay - An Advisory Vote on the Approval of Executive Compensation |
|
Management |
|
For |
|
For |
|
| 4. |
|
Say When on Pay - An Advisory Vote on the Approval of the Frequency of Shareholder Votes on Executive
Compensation |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder Proposal - Special Shareholder Meeting Threshold |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder Proposal - Independent Board Chairman |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder Proposal - Lobbying Disclosure |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder Proposal - Incentive Compensation |
|
Shareholder |
|
Against |
|
For |
|
ABBVIE INC.
| Security |
00287Y109 |
Meeting Type |
Annual |
| Ticker Symbol |
ABBV |
Meeting Date |
05-May-2023 |
| Record Date |
06-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Class II Director: Robert J. Alpern |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Class II Director: Melody B. Meyer |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Class II Director: Frederick H. Waddell |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Ernst & Young LLP as AbbVie’s independent registered public accounting firm
for 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Say on Pay - An advisory vote on the approval of executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate
supermajority voting. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Stockholder Proposal - to Implement Simple Majority Vote. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Stockholder Proposal - to Issue an Annual Report on Political Spending. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Stockholder Proposal - to Issue an Annual Report on Lobbying. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Stockholder Proposal - to Issue a Report on Patent Process. |
|
Shareholder |
|
Against |
|
For |
|
ACADIA HEALTHCARE COMPANY, INC.
| Security |
00404A109 |
Meeting Type |
Annual |
| Ticker Symbol |
ACHC |
Meeting Date |
18-May-2023 |
| Record Date |
23-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Michael J. Fucci |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Wade D. Miquelon |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approve an amendment and restatement of the Acadia Healthcare Company, Inc. Incentive Compensation
Plan as presented in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on the compensation of the Company’s named executive officers as presented in the Proxy
Statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public
accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
AFFIMED N.V
| Security |
N01045108 |
Meeting Type |
Annual |
| Ticker Symbol |
AFMD |
Meeting Date |
21-Jun-2023 |
| Record Date |
24-May-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 3. |
|
Adoption of the Statutory Annual Accounts for the financial year 2022 |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote (non-binding) on Executive Compensation |
|
Management |
|
For |
|
For |
|
| 5. |
|
Discharge of the managing directors for their management during the financial year 2022 |
|
Management |
|
For |
|
For |
|
| 6. |
|
Discharge of the supervisory directors for their supervision during the financial year 2022 |
|
Management |
|
For |
|
For |
|
| 7. |
|
Amendment of the Remuneration Policy for the Supervisory Board |
|
Management |
|
For |
|
For |
|
| 8a. |
|
Reappointment of Dr. Adi Hoess as a managing director |
|
Management |
|
For |
|
For |
|
| 8b. |
|
Reappointment of Dr. Wolfgang Fischer as a managing director |
|
Management |
|
For |
|
For |
|
| 8c. |
|
Reappointment of Mr. Angus Smith as a managing director |
|
Management |
|
For |
|
For |
|
| 8d. |
|
Reappointment of Dr. Arndt Schottelius as a managing director |
|
Management |
|
For |
|
For |
|
| 8e. |
|
Reappointment of Dr. Andreas Harstrick as a managing director |
|
Management |
|
For |
|
For |
|
| 9a. |
|
Reappointment of Dr. Thomas Hecht as a supervisory director |
|
Management |
|
For |
|
For |
|
| 9b. |
|
Reappointment of Mr. Harry Welten as a supervisory director |
|
Management |
|
For |
|
For |
|
| 9c. |
|
Reappointment of Dr. Annalisa M. Jenkins as a supervisory director |
|
Management |
|
For |
|
For |
|
| 9d. |
|
Appointment of Dr. Constanze Ulmer-Eilfort as a supervisory director |
|
Management |
|
For |
|
For |
|
| 10. |
|
Reverse stock split and amendment of the articles of association |
|
Management |
|
For |
|
For |
|
| 11. |
|
Authorization to acquire shares |
|
Management |
|
For |
|
For |
|
| 12. |
|
Appointment of the auditor for the financial year 2023 |
|
Management |
|
For |
|
For |
|
ALIGN TECHNOLOGY, INC.
| Security |
016255101 |
Meeting Type |
Annual |
| Ticker Symbol |
ALGN |
Meeting Date |
17-May-2023 |
| Record Date |
23-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Kevin J. Dallas |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Joseph M. Hogan |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Joseph Lacob |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: C. Raymond Larkin, Jr. |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: George J. Morrow |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Anne M. Myong |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: Andrea L. Saia |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Susan E. Siegel |
|
Management |
|
For |
|
For |
|
| 2. |
|
AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION: Proposal to approve the amendment
to our Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
ADVISORY VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation
of our Named Executive Officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
ADVISORY VOTE ON FREQUENCY OF STOCKHOLDERS’ APPROVAL OF EXECUTIVES COMPENSATION: Consider an Advisory
Vote to Approve the Frequency of Stockholders Advisory Vote on Named Executive Officers’ Compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
AMENDMENT TO INCENTIVE PLAN: Approve the Amendment to our 2005 Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the
appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.’s independent registered public accountants for the fiscal
year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
AMGEN INC.
| Security |
031162100 |
Meeting Type |
Annual |
| Ticker Symbol |
AMGN |
Meeting Date |
19-May-2023 |
| Record Date |
20-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Wanda M.
Austin |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Robert A.
Bradway |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Michael V.
Drake |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Brian J.
Druker |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Robert A.
Eckert |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Greg C. Garland |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Charles M.
Holley, Jr. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Dr. S. Omar Ishrak |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Tyler Jacks |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Ms. Ellen J.
Kullman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Ms. Amy E. Miles |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Ronald D.
Sugar |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director for a term of office expiring at the 2024 annual meeting: Dr. R. Sanders
Williams |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote on the frequency of future stockholder advisory votes to approve executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 3. |
|
Advisory vote to approve our executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To ratify the selection of Ernst & Young LLP as our independent registered public accountants
for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
AMOLYT PHARMA
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
21-Jun-2023 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Approval of the company’s 2022 financials and earnings, discharge of the President for the
performance of his duties during the past fiscal year |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval of amendment No. 1 dated November 13, 2022 and the amendment No. 2 dated
January 6, 2023 to the service agreement entered into on July 25, 2019 between the Company and Tab Consulting, of which
Mr. Thierry Abribat is chairman, the terms of which are described in the special report of the Statutory Auditor |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval of amendment No.2 dated April 7, 2022 and the amendment No. 3 dated March 8,
2023 to the consulting agreement entered into on May 6, 2020 between the Company and Stone Atlanta Estates LLC (formerly Stone
Sunny Isles, Inc.), of which Mr. Pierre Legault is president, the terms of which are described in the special report of
the Statutory Auditor |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval of amendment No.1 dated January 6, 2023 to the indemnification agreement entered into
on June 3, 2020 between the Company and Mr. Pierre Legault, the terms of which are described in the special report of the
Statutory Auditor. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Reappointment of Pierre Legault as a member of the Board of Directors |
|
Management |
|
For |
|
For |
|
| 6. |
|
Approval of the 2023-1 stock option plan adopted by the President on March 1, 2023 |
|
Management |
|
For |
|
For |
|
ARDELYX, INC
| Security |
039697107 |
Meeting Type |
Annual |
| Ticker Symbol |
ARDX |
Meeting Date |
15-Jun-2023 |
| Record Date |
18-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
Robert Bazemore |
|
|
|
For |
|
For |
|
| |
|
2 |
Muna Bhanji, R.Ph |
|
|
|
For |
|
For |
|
| |
|
3 |
Richard Rodgers |
|
|
|
For |
|
For |
|
| 2. |
|
To approve an amendment to our Amended and Restated Certificate of Incorporation to increase
the number of authorized shares of common stock from 300,000,000 to 500,000,000 shares. |
|
Management |
|
Against |
|
Against |
|
| 3. |
|
To approve, on a non-binding, advisory basis, the compensation of our named executive
officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities
and Exchange Commission (“Say-on- Pay”). |
|
Management |
|
For |
|
For |
|
| 4. |
|
To ratify the selection, by the Audit and Compliance Committee of our Board of Directors,
of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31,
2023. |
|
Management |
|
For |
|
For |
|
ARGENX SE
| Security |
04016X101 |
Meeting Type |
Special |
| Ticker Symbol |
ARGX |
Meeting Date |
12-Dec-2022 |
| Record Date |
08-Nov-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 2. |
|
Appointment of Ana Cespedes as non-executive director to
the board of directors of the Company |
|
Management |
|
Abstain |
|
|
|
ARGENX SE
| Security |
04016X101 |
Meeting Type |
Annual |
| Ticker Symbol |
ARGX |
Meeting Date |
02-May-2023 |
| Record Date |
04-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 3. |
|
Advisory vote to approve the 2022 remuneration report. |
|
Management |
|
For |
|
|
|
| 4b. |
|
Adoption of the 2022 annual accounts. |
|
Management |
|
For |
|
|
|
| 4d. |
|
Allocation of losses of the Company in the financial year 2021 to the retained earnings of the Company. |
|
Management |
|
For |
|
|
|
| 4e. |
|
Proposal to release the members of the board of directors from liability for their respective duties
carried out in the financial year 2022. |
|
Management |
|
For |
|
|
|
| 5. |
|
Proposal to re-appoint Don deBethizy as non-executive director for a term of two years. |
|
Management |
|
For |
|
|
|
| 6. |
|
Authorization of the board of directors to issue shares and grant rights to subscribe for shares
in the share capital of the Company up to a maximum of 10% of the outstanding capital at the date of the general meeting, for a period
of 18 months from the annual general meeting and to limit or exclude statutory pre-emptive rights, if any. |
|
Management |
|
For |
|
|
|
| 7. |
|
Appointment of Deloitte Accountants B.V. as statutory auditor for the 2023 financial year. |
|
Management |
|
For |
|
|
|
ARISTEA THERAPEUTICS, INC.
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
7-Jul-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Appoint Independent director |
|
Management |
|
For |
|
For |
|
ARISTEA THERAPEUTICS, INC.
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
7-Jul-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Appoint Series A director |
|
Management |
|
For |
|
For |
|
ASTRAZENECA PLC
| Security |
046353108 |
Meeting Type |
Annual |
| Ticker Symbol |
AZN |
Meeting Date |
27-Apr-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To receive the Company’s Accounts, the Reports of the Directors and Auditor and the Strategic Report
for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 2. |
|
To confirm dividends |
|
Management |
|
For |
|
For |
|
| 3. |
|
To reappoint PricewaterhouseCoopers LLP as Auditor |
|
Management |
|
For |
|
For |
|
| 4. |
|
To authorise the Directors to agree the remuneration of the Auditor |
|
Management |
|
For |
|
For |
|
| 5a. |
|
Re-election of Director: Michel Demaré |
|
Management |
|
For |
|
For |
|
| 5b. |
|
Re-election of Director: Pascal Soriot |
|
Management |
|
For |
|
For |
|
| 5c. |
|
Re-election of Director: Aradhana Sarin |
|
Management |
|
For |
|
For |
|
| 5d. |
|
Re-election of Director: Philip Broadley |
|
Management |
|
For |
|
For |
|
| 5e. |
|
Re-election of Director: Euan Ashley |
|
Management |
|
For |
|
For |
|
| 5f. |
|
Re-election of Director: Deborah DiSanzo |
|
Management |
|
For |
|
For |
|
| 5g. |
|
Re-election of Director: Diana Layfield |
|
Management |
|
For |
|
For |
|
| 5h. |
|
Re-election of Director: Sheri McCoy |
|
Management |
|
For |
|
For |
|
| 5i. |
|
Re-election of Director: Tony Mok |
|
Management |
|
For |
|
For |
|
| 5j. |
|
Re-election of Director: Nazneen Rahman |
|
Management |
|
For |
|
For |
|
| 5k. |
|
Re-election of Director: Andreas Rummelt |
|
Management |
|
For |
|
For |
|
| 5l. |
|
Re-election of Director: Marcus Wallenberg |
|
Management |
|
For |
|
For |
|
| 6. |
|
To approve the Annual Report on Remuneration for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 7. |
|
To authorise limited political donations |
|
Management |
|
For |
|
For |
|
| 8. |
|
To authorise the Directors to allot shares |
|
Management |
|
For |
|
For |
|
| 9. |
|
To authorise the Directors to disapply pre-emption rights (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 10. |
|
To authorise the Directors to further disapply pre-emption rights for acquisitions and specified
capital investments (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 11. |
|
To authorise the Company to purchase its own shares (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 12. |
|
To reduce the notice period for general meetings (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 13. |
|
To adopt new Articles of Association (Special Resolution) |
|
Management |
|
For |
|
For |
|
ASTRAZENECA PLC
| Security |
046353108 |
Meeting Type |
Annual |
| Ticker Symbol |
AZN |
Meeting Date |
27-Apr-2023 |
| Record Date |
04-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To receive the Company’s Accounts, the Reports of the Directors and Auditor and the Strategic Report
for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 2. |
|
To confirm dividends |
|
Management |
|
For |
|
For |
|
| 3. |
|
To reappoint PricewaterhouseCoopers LLP as Auditor |
|
Management |
|
For |
|
For |
|
| 4. |
|
To authorise the Directors to agree the remuneration of the Auditor |
|
Management |
|
For |
|
For |
|
| 5a. |
|
Re-election of Director: Michel Demaré |
|
Management |
|
For |
|
For |
|
| 5b. |
|
Re-election of Director: Pascal Soriot |
|
Management |
|
For |
|
For |
|
| 5c. |
|
Re-election of Director: Aradhana Sarin |
|
Management |
|
For |
|
For |
|
| 5d. |
|
Re-election of Director: Philip Broadley |
|
Management |
|
For |
|
For |
|
| 5e. |
|
Re-election of Director: Euan Ashley |
|
Management |
|
For |
|
For |
|
| 5f. |
|
Re-election of Director: Deborah DiSanzo |
|
Management |
|
For |
|
For |
|
| 5g. |
|
Re-election of Director: Diana Layfield |
|
Management |
|
For |
|
For |
|
| 5h. |
|
Re-election of Director: Sheri McCoy |
|
Management |
|
For |
|
For |
|
| 5i. |
|
Re-election of Director: Tony Mok |
|
Management |
|
For |
|
For |
|
| 5j. |
|
Re-election of Director: Nazneen Rahman |
|
Management |
|
For |
|
For |
|
| 5k. |
|
Re-election of Director: Andreas Rummelt |
|
Management |
|
For |
|
For |
|
| 5l. |
|
Re-election of Director: Marcus Wallenberg |
|
Management |
|
For |
|
For |
|
| 6. |
|
To approve the Annual Report on Remuneration for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 7. |
|
To authorise limited political donations |
|
Management |
|
For |
|
For |
|
| 8. |
|
To authorise the Directors to allot shares |
|
Management |
|
For |
|
For |
|
| 9. |
|
To authorise the Directors to disapply pre-emption rights (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 10. |
|
To authorise the Directors to further disapply pre-emption rights for acquisitions and specified
capital investments (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 11. |
|
To authorise the Company to purchase its own shares (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 12. |
|
To reduce the notice period for general meetings (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 13. |
|
To adopt new Articles of Association (Special Resolution) |
|
Management |
|
For |
|
For |
|
AVANTOR, INC.
| Security |
05352A100 |
Meeting Type |
Annual |
| Ticker Symbol |
AVTR |
Meeting Date |
11-May-2023 |
| Record Date |
17-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Juan Andres |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: John Carethers |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Lan Kang |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Joseph Massaro |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Mala Murthy |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Jonathan Peacock |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Michael Severino |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Christi Shaw |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Michael Stubblefield |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Gregory Summe |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the Appointment of Deloitte & Touche LLP as the Company’s independent registered
accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve, on an Advisory Basis, Named Executive Officer Compensation. |
|
Management |
|
For |
|
For |
|
BEIGENE LTD
| Security |
07725L102 |
Meeting Type |
Annual |
| Ticker Symbol |
BGNE |
Meeting Date |
15-Jun-2023 |
| Record Date |
17-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a Class I director of the
Company until the 2026 annual general meeting of the shareholders of the Company and until her successor is duly elected and qualified,
subject to her earlier resignation or removal. |
|
Management |
|
For |
|
For |
|
| 2. |
|
THAT John V. Oyler be and is hereby re-elected to serve as a Class I director of the Company
until the 2026 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject
to his earlier resignation or removal. |
|
Management |
|
For |
|
For |
|
| 3. |
|
THAT Dr. Alessandro Riva be and is hereby re-elected to serve as a Class I director until
the 2026 annual general meeting of shareholders and until his successor is duly electedand qualified, subject to his earlier resignation
or removal. |
|
Management |
|
For |
|
For |
|
| 4. |
|
THAT the selection of Ernst & Young LLP, Ernst & Young and Ernst & Young
Hua Ming LLP as the Company’s reporting accounting firms for the fiscal year ending December 31, 2023 be and is hereby approved,
ratified and confirmed. |
|
Management |
|
For |
|
For |
|
| 5. |
|
THAT the Board of Directors is hereby authorized to fix the auditors’ remuneration for the fiscal
year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 6. |
|
THAT the granting of a share issue mandate to the Board of ...(due to space limits, see proxy material
for full proposal). |
|
Management |
|
For |
|
For |
|
| 7. |
|
THAT the granting of a share repurchase mandate to the Board of ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 8. |
|
THAT the Company and its underwriters be and are hereby ...(due to space limits, see proxy material
for full proposal). |
|
Management |
|
For |
|
For |
|
| 9. |
|
THAT the Company and its underwriters be and are hereby ...(due to space limits, see proxy material
for full proposal). |
|
Management |
|
For |
|
For |
|
| 10. |
|
THAT the grant of an option to acquire shares to Amgen to allow ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 11. |
|
THAT the grant of restricted share units (“RSUs”) with a grant date fair value of US$5,500,000
to Mr. John V. Oyler under the Second Amended and Restated 2016 Share Option and Incentive Plan (as amended, the “2016
Plan”), according to the terms and conditions described in the Proxy Statement, be and is hereby approved. |
|
Management |
|
For |
|
For |
|
| 12. |
|
THAT the grant of RSUs with a grant date fair value of ...(due to space limits, see proxy material
for full proposal). |
|
Management |
|
For |
|
For |
|
| 13. |
|
THAT the grant of RSUs with a grant date fair value of ...(due to space limits, see proxy material
for full proposal). |
|
Management |
|
For |
|
For |
|
| 14. |
|
THAT, on a non-binding, advisory basis, the compensation of the ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 15. |
|
THAT the Seventh Amended and Restated Memorandum and Articles of Association of the Company, as described
in the Proxy Statement, be and is hereby approved. |
|
Management |
|
For |
|
For |
|
| 16. |
|
THAT the adjournment of the Annual Meeting by the chairman, if ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
BIOGEN INC.
| Security |
09062X103 |
Meeting Type |
Annual |
| Ticker Symbol |
BIIB |
Meeting Date |
26-Jun-2023 |
| Record Date |
20-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Caroline
D. Dorsa |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Maria
C. Freire |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: William
A. Hawkins |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Jesus
B. Mantas |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Eric K.
Rowinsky |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Stephen
A. Sherwin |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Christopher
A. Viehbacher |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.’s independent registered public
accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Say on Pay - To approve an advisory vote on executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Say When on Pay - To approve an advisory vote on the frequency of the advisory vote on executive
compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To elect Susan Langer as a director |
|
Management |
|
|
|
|
|
BIOHAVEN LTD
| Security |
G1110E107 |
Meeting Type |
Annual |
| Ticker Symbol |
BHVN |
Meeting Date |
02-May-2023 |
| Record Date |
06-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director for a term expiring at the 2026 Annual Meeting of shareholders: Michael T. Heffernan |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director for a term expiring at the 2026 Annual Meeting of shareholders: Irina A. Antonijevic,
M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director for a term expiring at the 2026 Annual Meeting of shareholders: Robert J. Hugin |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year
2023. |
|
Management |
|
For |
|
For |
|
BIOHAVEN PHARMACEUTICAL HLDG CO LTD
| Security |
G11196105 |
Meeting Type |
Special |
| Ticker Symbol |
BHVN |
Meeting Date |
29-Sep-2022 |
| Record Date |
29-Aug-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To adopt (i) the Agreement and Plan of Merger, dated as of May 9, 2022 (the “Merger
Agreement”), by and among Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven”), Pfizer Inc. & Bulldog
(BVI) Ltd., (ii) the form of Plan of Reverse Triangular Merger & form of Plan of Forward Triangular Merger (together,
the “Plan of Merger”) & (iii) Separation & Distribution Agreement, dated as of May 9, 2022
(“Distribution Agreement”), by and between Biohaven & Biohaven Research Ltd. (“SpinCo”), in each case,
as they may be amended from time to time. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, by non-binding, advisory vote, certain compensatory arrangements for Biohaven’s named
executive officers in connection with the acquisition by Pfizer of Biohaven and the distribution to Biohaven’s shareholders of all
of the issued and outstanding common shares of SpinCo. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To adjourn the Special Meeting, if necessary, desirable or appropriate, to solicit additional proxies
if, at the time of the Special Meeting, there are an insufficient number of votes to adopt the Merger Agreement, the Plan of Merger
and the Distribution Agreement. |
|
Management |
|
For |
|
For |
|
BOSTON SCIENTIFIC CORPORATION
| Security |
101137107 |
Meeting Type |
Annual |
| Ticker Symbol |
BSX |
Meeting Date |
04-May-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Nelda J. Connors |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Charles J. Dockendorff |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Yoshiaki Fujimori |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Edward J. Ludwig |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Michael F. Mahoney |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: David J. Roux |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: John E. Sununu |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: David S. Wichmann |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Ellen M. Zane |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding, advisory basis, the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation
of our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting
firm for the 2023 fiscal year. |
|
Management |
|
For |
|
For |
|
BRISTOL-MYERS SQUIBB COMPANY
| Security |
110122108 |
Meeting Type |
Annual |
| Ticker Symbol |
BMY |
Meeting Date |
02-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director: Peter J. Arduini |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director: Deepak L. Bhatt, M.D., M.P.H. |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director: Giovanni Caforio, M.D. |
|
Management |
|
For |
|
For |
|
| 1D. |
|
Election of Director: Julia A. Haller, M.D. |
|
Management |
|
For |
|
For |
|
| 1E. |
|
Election of Director: Manuel Hidalgo Medina, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1F. |
|
Election of Director: Paula A. Price |
|
Management |
|
For |
|
For |
|
| 1G. |
|
Election of Director: Derica W. Rice |
|
Management |
|
For |
|
For |
|
| 1H. |
|
Election of Director: Theodore R. Samuels |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Election of Director: Gerald L. Storch |
|
Management |
|
For |
|
For |
|
| 1J. |
|
Election of Director: Karen H. Vousden, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1K. |
|
Election of Director: Phyllis R. Yale |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Vote to Approve the Compensation of our Named Executive Officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on the Frequency of the Advisory Vote on the Compensation of our Named Executive Officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the Appointment of an Independent Registered Public Accounting Firm. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent
Director. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
Shareholder Proposal on Workplace Non-Discrimination Audit. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder Proposal on Special Shareholder Meeting Improvement. |
|
Shareholder |
|
Against |
|
For |
|
CHARLES RIVER LABORATORIES INTL., INC.
| Security |
159864107 |
Meeting Type |
Annual |
| Ticker Symbol |
CRL |
Meeting Date |
09-May-2023 |
| Record Date |
16-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: James C. Foster |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Nancy C. Andrews |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert Bertolini |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Deborah T. Kochevar |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: George Llado, Sr. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Martin W. Mackay |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: George E. Massaro |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: C. Richard Reese |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Craig B. Thompson |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Richard F. Wallman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Virginia M. Wilson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Approval of 2022 Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2023 |
|
Management |
|
For |
|
For |
|
| 5. |
|
Proposal to publish a report on non-human primates imported by Charles River Laboratories International, Inc. |
|
Management |
|
Against |
|
For |
|
COMMUNITY HEALTH SYSTEMS, INC.
| Security |
203668108 |
Meeting Type |
Annual |
| Ticker Symbol |
CYH |
Meeting Date |
09-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Susan W. Brooks |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: John A. Clerico |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Michael Dinkins |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: James S. Ely III |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: John A. Fry |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Joseph A. Hastings, D.M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Tim L. Hingtgen |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Elizabeth T. Hirsch |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: William Norris Jennings, M.D. |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: K. Ranga Krishnan, MBBS |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Wayne T. Smith |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: H. James Williams, Ph.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Proposal to approve on an advisory (non-binding) basis the compensation of the Company’s named executive
officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Proposal to approve on an advisory (non-binding) basis the frequency of future advisory votes on
the compensation of the Company’s named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009
Stock Option and Award Plan, which was approved by the Board of Directors on March 22, 2023, subject to stockholder approval. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
COMMUNITY HEALTHCARE TRUST INCORPORATED
| Security |
20369C106 |
Meeting Type |
Annual |
| Ticker Symbol |
CHCT |
Meeting Date |
04-May-2023 |
| Record Date |
02-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
Cathrine Cotman |
|
|
|
For |
|
For |
|
| |
|
2 |
David Dupuy |
|
|
|
For |
|
For |
|
| |
|
3 |
Alan Gardner |
|
|
|
For |
|
For |
|
| |
|
4 |
Claire Gulmi |
|
|
|
For |
|
For |
|
| |
|
5 |
Robert Hensley |
|
|
|
For |
|
For |
|
| |
|
6 |
Lawrence Van Horn |
|
|
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding advisory basis, the following resolutions: RESOLVED, that
the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named
executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company’s proxy statement for the 2023 annual meeting
of stockholders. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the appointment of BDO USA, LLP as the Company’s independent registered public
accountants for 2023. |
|
Management |
|
For |
|
For |
|
DANAHER CORPORATION
| Security |
235851102 |
Meeting Type |
Annual |
| Ticker Symbol |
DHR |
Meeting Date |
09-May-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Rainer M. Blair |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Feroz Dewan |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Linda Filler |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Teri List |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Walter G. Lohr, Jr. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Jessica L. Mega,
MD, MPH |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Mitchell P. Rales |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Steven M. Rales |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Pardis C. Sabeti,
MD, D. PHIL |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: A. Shane Sanders |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: John T. Schwieters |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Alan G. Spoon |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Raymond C. Stevens,
Ph.D |
|
Management |
|
For |
|
For |
|
| 1n. |
|
Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Elias A. Zerhouni,
MD |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection of Ernst & Young LLP as Danaher’s independent registered public
accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve on an advisory basis the Company’s named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To hold an advisory vote relating to the frequency of future shareholder advisory votes on the Company’s
executive officer compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To act upon a shareholder proposal requesting adoption of a policy separating the chair and CEO roles
and requiring an independent Board Chair whenever possible. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
To act upon a shareholder proposal requesting a report to shareholders on the effectiveness of the
Company’s diversity, equity and inclusion efforts. |
|
Shareholder |
|
Against |
|
For |
|
DEXCOM, INC.
| Security |
252131107 |
Meeting Type |
Annual |
| Ticker Symbol |
DXCM |
Meeting Date |
18-May-2023 |
| Record Date |
29-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director to hold office until our 2024 Annual Meeting: Steven R. Altman |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director to hold office until our 2024 Annual Meeting: Richard A. Collins |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director to hold office until our 2024 Annual Meeting: Karen Dahut |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director to hold office until our 2024 Annual Meeting: Mark G. Foletta |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director to hold office until our 2024 Annual Meeting: Barbara E. Kahn |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director to hold office until our 2024 Annual Meeting: Kyle Malady |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director to hold office until our 2024 Annual Meeting: Eric J. Topol, M.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young
LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To hold a non-binding vote on an advisory resolution to approve executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To recommend a non-binding advisory resolution on the frequency of stockholder votes on executive
compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To hold a non-binding vote on pay equity disclosure. |
|
Management |
|
Against |
|
For |
|
DIVERSIFIED HEALTHCARE TRUST
| Security |
25525P107 |
Meeting Type |
Annual |
| Ticker Symbol |
DHC |
Meeting Date |
05-Jun-2023 |
| Record Date |
17-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Independent Trustee: John L. Harrington |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Independent Trustee: Lisa Harris Jones |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Independent Trustee: Daniel F. LePage |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Independent Trustee: David A. Pierce |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Independent Trustee: Jeffrey P. Somers |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Managing Trustee: Jennifer F. Francis |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Managing Trustee: Adam D. Portnoy |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on the frequency of future advisory votes to approve executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve
for the 2023 fiscal year. |
|
Management |
|
For |
|
For |
|
DYNACURE
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
10-Oct-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To approve the Term Sheet and the principle of the Merger subject to the terms and conditions set
forth therein; and |
|
Management |
|
For |
|
For |
|
| 2. |
|
To waive their rights to the liquidation preference under the Shareholders’ Agreement in connection
with the contemplated Merger, subject to their replacement by new preference rights as described in the Term Sheet |
|
Management |
|
For |
|
For |
|
DYNACURE
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
23-Jan-2023 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Merger with Flamingo |
|
Management |
|
For |
|
For |
|
EDWARDS LIFESCIENCES CORPORATION
| Security |
28176E108 |
Meeting Type |
Annual |
| Ticker Symbol |
EW |
Meeting Date |
11-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Kieran T. Gallahue |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Leslie S. Heisz |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Paul A. LaViolette |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: Steven R. Loranger |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: Martha H. Marsh |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Michael A. Mussallem |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: Ramona Sequeira |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Nicholas J. Valeriani |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director: Bernard J. Zovighian |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Vote to Approve Named Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote to Approve Frequency of Future Advisory Votes on Named Executive Officer Compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of Appointment of Independent Registered Public Accounting Firm |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of Amendment of the Certificate of Incorporation to Provide for Exculpation of Officers |
|
Management |
|
For |
|
For |
|
| 6. |
|
Stockholder Proposal regarding Independent Board Chairman Policy |
|
Shareholder |
|
Against |
|
For |
|
ELEVANCE HEALTH, INC.
| Security |
036752103 |
Meeting Type |
Annual |
| Ticker Symbol |
ELV |
Meeting Date |
10-May-2023 |
| Record Date |
17-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Gail K. Boudreaux |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: R. Kerry Clark |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert L. Dixon, Jr. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Deanna D. Strable |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on the frequency of the advisory vote to approve the compensation of our named executive
officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting
firm for 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal to allow shareholders owning 10% or more of our common stock to call a special
meeting of shareholders. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder proposal requesting annual reporting from third parties seeking financial support. |
|
Shareholder |
|
Against |
|
For |
|
ELI LILLY AND COMPANY
| Security |
532457108 |
Meeting Type |
Annual |
| Ticker Symbol |
LLY |
Meeting Date |
01-May-2023 |
| Record Date |
21-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to serve a three-year term: William G. Kaelin, Jr. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to serve a three-year term: David A. Ricks |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to serve a three-year term: Marschall S. Runge |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to serve a three-year term: Karen Walker |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval, on an advisory basis, of the compensation paid to the company’s named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on frequency of future advisory votes on named executive officer compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of amendments to the company’s Articles of Incorporation to eliminate the classified board
structure. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Approval of amendments to the company’s Articles of Incorporation to eliminate supermajority voting
provisions. |
|
Management |
|
For |
|
For |
|
| 7. |
|
Shareholder proposal to publish an annual report disclosing lobbying activities. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder proposal to eliminate supermajority voting requirements. |
|
Shareholder |
|
Against |
|
For |
|
| 9. |
|
Shareholder proposal to establish and report on a process by which the impact of extended patent
exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents. |
|
Shareholder |
|
Against |
|
For |
|
| 10. |
|
Shareholder proposal to report on risks of supporting abortion. |
|
Shareholder |
|
Against |
|
For |
|
| 11. |
|
Shareholder proposal to disclose lobbying activities and alignment with public policy positions and
statements. |
|
Shareholder |
|
Against |
|
For |
|
| 12. |
|
Shareholder proposal to report on effectiveness of the company’s diversity, equity, and inclusion
efforts. |
|
Shareholder |
|
Against |
|
For |
|
| 13. |
|
Shareholder proposal to adopt a policy to require certain third-party organizations to annually report
expenditures for political activities before Lilly contributes to an organization. |
|
Shareholder |
|
Against |
|
For |
|
FLAMINGO THERAPEUTICS, INC
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
28-Mar-2023 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Reports |
|
Management |
|
For |
|
For |
|
| 2. |
|
Creation of new classes of shares according to the report of the board of directors in accordance
with Articles 7:155, 7:179, 7:180 and 7:191 of the Companies and Associations Code |
|
Management |
|
For |
|
For |
|
| 3. |
|
Issue of new shares by capital increase in cash |
|
Management |
|
For |
|
For |
|
| 4. |
|
Cancellation and issuance of subscription rights |
|
Management |
|
For |
|
For |
|
| 5. |
|
Issue of anti-dilutive subscription rights |
|
Management |
|
For |
|
For |
|
| 6. |
|
Confirmation of the cancellation of all securities or rights giving access to the capital of Dynacure
SA in the context of the merger |
|
Management |
|
For |
|
For |
|
| 7. |
|
Proxies |
|
Management |
|
For |
|
For |
|
FLAMINGO THERAPEUTICS, INC
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
19-May-2023 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Acknowledgment of the report of the statutory auditor |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval of the annual accounts for the fiscal year ended on 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 3. |
|
Allocation of the results |
|
Management |
|
For |
|
For |
|
| 4. |
|
Release of liability to the directors and the statutory auditor for the exercise of their mandate
during the past fiscal year |
|
Management |
|
For |
|
For |
|
FUSION PHARMACEUTICALS INC
| Security |
36118A100 |
Meeting Type |
Annual |
| Ticker Symbol |
FUSN |
Meeting Date |
14-Jun-2023 |
| Record Date |
18-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director to serve until the next annual meeting: Donald Bergstrom, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director to serve until the next annual meeting: Pablo Cagnoni, M.D. |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director to serve until the next annual meeting: Johan Christenson, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director to serve until the next annual meeting: Barbara Duncan |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director to serve until the next annual meeting: Steve Gannon |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director to serve until the next annual meeting: Chau Khuong |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director to serve until the next annual meeting: Philina Lee, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director to serve until the next annual meeting: Heather Preston, M.D. |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director to serve until the next annual meeting: John Valliant, Ph.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To appoint PricewaterhouseCoopers LLP as our independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
GALERA THERAPEUTICS, INC.
| Security |
36338D108 |
Meeting Type |
Annual |
| Ticker Symbol |
GRTX |
Meeting Date |
14-Jun-2023 |
| Record Date |
21-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
Michael Powell, Ph.D. |
|
|
|
For |
|
For |
|
| |
|
2 |
Linda West |
|
|
|
For |
|
For |
|
| 2. |
|
To ratify the appointment of KPMG LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
GILEAD SCIENCES, INC.
| Security |
375558103 |
Meeting Type |
Annual |
| Ticker Symbol |
GILD |
Meeting Date |
03-May-2023 |
| Record Date |
15-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Jacqueline K. Barton, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Jeffrey A. Bluestone, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Sandra J. Horning, M.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Kelly A. Kramer |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kevin E. Lofton |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Harish Manwani |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Daniel P. O’Day |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Javier J. Rodriguez |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Anthony Welters |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection of Ernst & Young LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in
the Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve, on an advisory basis, the frequency of future advisory stockholder votes on executive
compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To approve an amendment and restatement of the Gilead Sciences, Inc. Employee Stock Purchase
Plan and the Gilead Sciences, Inc. International Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
To vote on a stockholder proposal, if properly presented at the meeting, requesting the Board implement
a process to nominate at least one more candidate than the number of directors to be elected. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
To vote on a stockholder proposal, if properly presented at the meeting, requesting the Board amend
the company governing documents to give street name shares and non-street name shares an equal right to call a special stockholder
meeting. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
To vote on a stockholder proposal, if properly presented at the meeting, requesting a report on a
process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for
secondary and tertiary patents. |
|
Shareholder |
|
Against |
|
For |
|
GLOBAL MEDICAL REIT INC.
| Security |
37954A204 |
Meeting Type |
Annual |
| Ticker Symbol |
GMRE |
Meeting Date |
10-May-2023 |
| Record Date |
15-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director to serve until next annual meeting: Jeffrey M. Busch |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director to serve until next annual meeting: Matthew Cypher |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director to serve until next annual meeting: Ronald Marston |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director to serve until next annual meeting: Henry E. Cole |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director to serve until next annual meeting: Zhang Huiqi |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director to serve until next annual meeting: Paula R. Crowley |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director to serve until next annual meeting: Lori Wittman |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve the compensation of the Company’s named executive officers as described
in the accompanying Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered
public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
GSK PLC
| Security |
37733W204 |
Meeting Type |
Annual |
| Ticker Symbol |
GSK |
Meeting Date |
03-May-2023 |
| Record Date |
16-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To receive and adopt the 2022 Annual Report |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve the Annual report on remuneration |
|
Management |
|
For |
|
For |
|
| 3. |
|
To elect Julie Brown as a Director |
|
Management |
|
For |
|
For |
|
| 4. |
|
To elect Dr Vishal Sikka as a Director |
|
Management |
|
For |
|
For |
|
| 5. |
|
To elect Elizabeth McKee Anderson as a Director |
|
Management |
|
For |
|
For |
|
| 6. |
|
To re-elect Sir Jonathan Symonds as a Director |
|
Management |
|
For |
|
For |
|
| 7. |
|
To re-elect Dame Emma Walmsley as a Director |
|
Management |
|
For |
|
For |
|
| 8. |
|
To re-elect Charles Bancroft as a Director |
|
Management |
|
For |
|
For |
|
| 9. |
|
To re-elect Dr Hal Barron as a Director |
|
Management |
|
For |
|
For |
|
| 10. |
|
To re-elect Dr Anne Beal as a Director |
|
Management |
|
For |
|
For |
|
| 11. |
|
To re-elect Dr Harry C Dietz as a Director |
|
Management |
|
For |
|
For |
|
| 12. |
|
To re-elect Dr Jesse Goodman as a Director |
|
Management |
|
For |
|
For |
|
| 13. |
|
To re-elect Urs Rohner as a Director |
|
Management |
|
For |
|
For |
|
| 14. |
|
To re-appoint the auditor |
|
Management |
|
For |
|
For |
|
| 15. |
|
To determine remuneration of the auditor |
|
Management |
|
For |
|
For |
|
| 16. |
|
To approve amendments to the Directors’ Remuneration policy |
|
Management |
|
For |
|
For |
|
| 17. |
|
To authorise the company and its subsidiaries to make donations to political organisations and incur
political expenditure |
|
Management |
|
For |
|
For |
|
| 18. |
|
To authorise allotment of shares |
|
Management |
|
For |
|
For |
|
| 19. |
|
To disapply pre-emption rights - general power (Special resolution) |
|
Management |
|
For |
|
For |
|
| 20. |
|
To disapply pre-emption rights - in connection with an acquisition or specified capital investment
(Special resolution) |
|
Management |
|
For |
|
For |
|
| 21. |
|
To authorise the company to purchase its own shares (Special resolution) |
|
Management |
|
For |
|
For |
|
| 22. |
|
To authorise exemption from statement of name of senior statutory auditor |
|
Management |
|
For |
|
For |
|
| 23. |
|
To authorise reduced notice of a general meeting other than an AGM (Special resolution) |
|
Management |
|
For |
|
For |
|
GUARDANT HEALTH, INC.
| Security |
40131M109 |
Meeting Type |
Annual |
| Ticker Symbol |
GH |
Meeting Date |
14-Jun-2023 |
| Record Date |
17-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Class II Director: Ian Clark |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Class II Director: Meghan Joyce |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Class II Director: Samir Kaul |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.’s
independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Non-binding advisory vote to approve Guardant Health, Inc.’s named executive officer compensation. |
|
Management |
|
For |
|
For |
|
HCA HEALTHCARE, INC.
| Security |
40412C101 |
Meeting Type |
Annual |
| Ticker Symbol |
HCA |
Meeting Date |
19-Apr-2023 |
| Record Date |
24-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Thomas F. Frist III |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Samuel N. Hazen |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Meg G. Crofton |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Robert J. Dennis |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Nancy-Ann DeParle |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: William R. Frist |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Hugh F. Johnston |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Michael W. Michelson |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Wayne J. Riley, M.D. |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Andrea B. Smith |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting
firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve the HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Stockholder proposal, if properly presented at the meeting, regarding amendment to Patient Safety
and Quality of Care Committee charter. |
|
Shareholder |
|
Against |
|
For |
|
HEALTHCARE REALTY TRUST INCORPORATED
| Security |
42226K105 |
Meeting Type |
Annual |
| Ticker Symbol |
HR |
Meeting Date |
05-Jun-2023 |
| Record Date |
14-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Todd J. Meredith |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: John V. Abbott |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Nancy H. Agee |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: W. Bradley Blair II |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Vicki U. Booth |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Edward H. Braman |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Ajay Gupta |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: James J. Kilroy |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Jay P. Leupp |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Peter F. Lyle |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Constance B. Moore |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: John Knox Singleton |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director: Christann M. Vasquez |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for
the Company and its subsidiaries for the Company’s 2023 fiscal year. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders
of Healthcare Realty Trust Incorporated approve, on a non- binding advisory basis, the compensation of the Named Executive Officers
as disclosed pursuant to Item 402 of Regulation S-K in the Company’s proxy statement for the 2023 Annual Meeting of Stockholders. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve, on a non-binding advisory basis, the frequency of a non-binding advisory vote on executive
compensation. |
|
Management |
|
1 Year |
|
For |
|
HEALTHCARE TRUST OF AMERICA, INC.
| Security |
42225P501 |
Meeting Type |
Special |
| Ticker Symbol |
HTA |
Meeting Date |
15-Jul-2022 |
| Record Date |
10-Jun-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Company Issuance Proposal. To approve the issuance of shares of class A common stock, $0.01 par value
per share (“Company Common Stock”), of Healthcare Trust of America, Inc. (the “Company”), pursuant to the
Agreement and Plan of Merger, dated as of February 28, 2022, by and among the Company, Healthcare Trust of America Holdings,
LP, Healthcare Realty Trust Incorporated, and HR Acquisition 2, LLC (the “Merger”). |
|
Management |
|
For |
|
For |
|
| 2. |
|
Company Golden Parachute Proposal. To approve, in a non-binding advisory vote, the “golden parachute”
compensation that may become vested and payable to the Company’s named executive officers in connection with the Merger. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Company Adjournment Proposal. To approve one or more adjournments of the Company Special Meeting
to another date, time, place, or format, if necessary or appropriate, including to solicit additional proxies in favor of the proposal
to approve the issuance of shares of Company Common Stock in connection with the Merger. |
|
Management |
|
For |
|
For |
|
HEALTHPEAK PROPERTIES, INC
| Security |
42250P103 |
Meeting Type |
Annual |
| Ticker Symbol |
PEAK |
Meeting Date |
27-Apr-2023 |
| Record Date |
01-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Scott M. Brinker |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Brian G. Cartwright |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: James B. Connor |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Christine N. Garvey |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: R. Kent Griffin, Jr. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: David B. Henry |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Sara G. Lewis |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Katherine M. Sandstrom |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval of 2022 executive compensation on an advisory basis. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Approval of the Healthpeak Properties, Inc. 2023 Performance Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.’s
independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
HORIZON THERAPEUTICS PLC
| Security |
G46188101 |
Meeting Type |
Special |
| Ticker Symbol |
HZNP |
Meeting Date |
24-Feb-2023 |
| Record Date |
19-Jan-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Ordinary Resolution to approve the Scheme of Arrangement and authorize the directors of Horizon to
take all such actions as they consider necessary or appropriate for carrying the Scheme of Arrangement into effect. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Special Resolution to amend the articles of association of Horizon so that any Horizon Shares that
are issued on or after the Voting Record Time to persons other than Acquirer Sub or its nominee(s) will either be subject to
the terms of the Scheme of Arrangement or be immediately and automatically acquired by Acquirer Sub and/or its nominee(s) for
the Scheme Consideration. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Ordinary Resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements
between Horizon and its named executive officers relating to the Transaction. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Ordinary Resolution to approve any motion by the Chairman to adjourn the EGM or any adjournments
thereof, to solicit additional proxies in favor of the approval of the resolutions if there are insufficient votes at the time of
the EGM to approve resolutions 1 and 2. |
|
Management |
|
For |
|
For |
|
HORIZON THERAPEUTICS PLC
| Security |
G46188111 |
Meeting Type |
Special |
| Ticker Symbol |
HZNP |
Meeting Date |
24-Feb-2023 |
| Record Date |
19-Jan-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
That the Scheme of Arrangement in its original form or with or subject to any modification(s), addition(s) or
condition(s) approved or imposed by the Irish High Court be agreed to. |
|
Management |
|
For |
|
For |
|
HUMANA INC.
| Security |
444859102 |
Meeting Type |
Annual |
| Ticker Symbol |
HUM |
Meeting Date |
20-Apr-2023 |
| Record Date |
28-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a) |
|
Election of Director: Raquel C. Bono, M.D. |
|
Management |
|
For |
|
For |
|
| 1b) |
|
Election of Director: Bruce D. Broussard |
|
Management |
|
For |
|
For |
|
| 1c) |
|
Election of Director: Frank A. D’Amelio |
|
Management |
|
For |
|
For |
|
| 1d) |
|
Election of Director: David T. Feinberg, M.D. |
|
Management |
|
For |
|
For |
|
| 1e) |
|
Election of Director: Wayne A. I. Frederick, M.D. |
|
Management |
|
For |
|
For |
|
| 1f) |
|
Election of Director: John W. Garratt |
|
Management |
|
For |
|
For |
|
| 1g) |
|
Election of Director: Kurt J. Hilzinger |
|
Management |
|
For |
|
For |
|
| 1h) |
|
Election of Director: Karen W. Katz |
|
Management |
|
For |
|
For |
|
| 1i) |
|
Election of Director: Marcy S. Klevorn |
|
Management |
|
For |
|
For |
|
| 1j) |
|
Election of Director: William J. McDonald |
|
Management |
|
For |
|
For |
|
| 1k) |
|
Election of Director: Jorge S. Mesquita |
|
Management |
|
For |
|
For |
|
| 1l) |
|
Election of Director: Brad D. Smith |
|
Management |
|
For |
|
For |
|
| 2. |
|
The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered
public accounting firm. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Non-binding advisory vote for the approval of the compensation of the named executive officers as
disclosed in the 2023 proxy statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Non-binding advisory vote for the approval of the frequency with which future stockholder votes on
the compensation of the named executive officers will be held. |
|
Management |
|
1 Year |
|
For |
|
ICON PLC
| Security |
G4705A100 |
Meeting Type |
Annual |
| Ticker Symbol |
ICLR |
Meeting Date |
26-Jul-2022 |
| Record Date |
06-Jun-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Dr. Steve Cutler |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Dr. John Climax |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Mr. Ronan Murphy |
|
Management |
|
For |
|
For |
|
| 2. |
|
To review the Company’s affairs and consider the Accounts and Reports |
|
Management |
|
For |
|
For |
|
| 3. |
|
To authorise the fixing of the Auditors’ Remuneration |
|
Management |
|
For |
|
For |
|
| 4. |
|
To authorise the Company to allot shares |
|
Management |
|
For |
|
For |
|
| 5. |
|
To disapply the statutory pre-emption rights |
|
Management |
|
For |
|
For |
|
| 6. |
|
To disapply the statutory pre-emption rights for funding capital investment or acquisitions |
|
Management |
|
For |
|
For |
|
| 7. |
|
To authorise the Company to make market purchases of shares |
|
Management |
|
For |
|
For |
|
| 8. |
|
To authorise the price range at which the Company can reissue shares that it holds as treasury shares |
|
Management |
|
For |
|
For |
|
IDEXX LABORATORIES, INC.
| Security |
45168D104 |
Meeting Type |
Annual |
| Ticker Symbol |
IDXX |
Meeting Date |
17-May-2023 |
| Record Date |
20-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director (Proposal One): Daniel M. Junius |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director (Proposal One): Lawrence D. Kingsley |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director (Proposal One): Sophie V. Vandebroek, PhD |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection
of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the current fiscal year (Proposal
Two). |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company’s
executive compensation (Proposal Three). |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory Vote on the Frequency of Advisory Votes on Executive Compensation. To recommend, by nonbinding
advisory vote, the frequency of future advisory votes on the Company’s executive compensation (Proposal Four). |
|
Management |
|
1 Year |
|
For |
|
ILLUMINA, INC.
| Security |
452327109 |
Meeting Type |
Contested-Annual |
| Ticker Symbol |
ILMN |
Meeting Date |
25-May-2023 |
| Record Date |
03-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Illumina Nominee: Frances Arnold, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Illumina Nominee: Francis A. deSouza |
|
Management |
|
Withheld |
|
For |
|
| 1C. |
|
Illumina Nominee: Caroline D. Dorsa |
|
Management |
|
Withheld |
|
For |
|
| 1D. |
|
Illumina Nominee: Robert S. Epstein, M.D. |
|
Management |
|
Withheld |
|
For |
|
| 1E. |
|
Illumina Nominee: Scott Gottlieb, M.D. |
|
Management |
|
For |
|
For |
|
| 1F. |
|
Illumina Nominee: Gary S. Guthart, Ph.D. |
|
Management |
|
Withheld |
|
For |
|
| 1G. |
|
Illumina Nominee: Philip W. Schiller |
|
Management |
|
For |
|
For |
|
| 1H. |
|
Illumina Nominee: Susan E. Siegel |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Illumina Nominee: John W. Thompson |
|
Management |
|
Withheld |
|
For |
|
| 1J. |
|
Icahn Group Nominee OPPOSED by the Company: Vincent J. Intrieri |
|
Management |
|
For |
|
For |
|
| 1K. |
|
Icahn Group Nominee OPPOSED by the Company: Jesse A. Lynn |
|
Management |
|
Withheld |
|
For |
|
| 1L. |
|
Icahn Group Nominee OPPOSED by the Company: Andrew J. Teno |
|
Management |
|
Withheld |
|
For |
|
| 2. |
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on an advisory basis, the compensation provided to our named executive officers as disclosed
in the Proxy Statement. |
|
Management |
|
Against |
|
Against |
|
| 4. |
|
To approve, on an advisory basis, the frequency of holding an advisory vote to approve compensation
provided to our “named executive officers”. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan |
|
Management |
|
For |
|
For |
|
INTUITIVE SURGICAL, INC.
| Security |
46120E602 |
Meeting Type |
Annual |
| Ticker Symbol |
ISRG |
Meeting Date |
27-Apr-2023 |
| Record Date |
28-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Craig H. Barratt, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Joseph C. Beery |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Gary S. Guthart, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Amal M. Johnson |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Don R. Kania, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Amy L. Ladd, M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Keith R. Leonard, Jr. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Alan J. Levy, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Jami Dover Nachtsheim |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Monica P. Reed, M.D. |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Mark J. Rubash |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, by advisory vote, the compensation of the Company’s Named Executive Officers |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, by advisory vote, the frequency of the advisory vote on the compensation of the Company’s
Named Executive Officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
The ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
The stockholder proposal regarding pay equity disclosure. |
|
Shareholder |
|
Against |
|
For |
|
IO LIGHT HOLDINGS, INC.
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
27-Sep-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Approval of Subsidiary Transfer Documents |
|
Management |
|
For |
|
For |
|
| 2. |
|
General Resolutions |
|
Management |
|
For |
|
For |
|
IO LIGHT HOLDINGS, INC.
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
30-Dec-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Approval of Series B Financing |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval of Amended and Restated Certification of Incorporation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval of Amended and Restated Stockholders Agreement |
|
Management |
|
1 Year |
|
For |
|
IQVIA HOLDINGS INC.
| Security |
46266C105 |
Meeting Type |
Annual |
| Ticker Symbol |
IQV |
Meeting Date |
18-Apr-2023 |
| Record Date |
17-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Carol J. Burt |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Colleen A. Goggins |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Sheila A. Stamps |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approve an advisory (non-binding) resolution to approve IQVIA’s executive compensation (say-on-pay). |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve a Company proposal to amend IQVIA’s Certificate of Incorporation to adopt a stockholders’
right to request a special stockholders’ meeting. |
|
Management |
|
For |
|
For |
|
| 4. |
|
If properly presented, a stockholder proposal concerning special stockholder meetings. |
|
Shareholder |
|
For |
|
Against |
|
| 5. |
|
If properly presented, a stockholder proposal for separate Chairman and Chief Executive Officer roles. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA’s independent registered public
accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
JOHNSON & JOHNSON
| Security |
478160104 |
Meeting Type |
Annual |
| Ticker Symbol |
JNJ |
Meeting Date |
27-Apr-2023 |
| Record Date |
28-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Darius Adamczyk |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Mary C. Beckerle |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: D. Scott Davis |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Jennifer A. Doudna |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Joaquin Duato |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Marillyn A. Hewson |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Paula A. Johnson |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Hubert Joly |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Election of Director: Mark B. McClellan |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Anne M. Mulcahy |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Mark A. Weinberger |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: Nadja Y. West |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Vote to Approve Named Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on the Frequency of Voting to Approve Named Executive Officer Compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered
Public Accounting Firm |
|
Management |
|
For |
|
For |
|
| 5. |
|
Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw) |
|
Shareholder |
|
Abstain |
|
|
|
| 6. |
|
Vaccine Pricing Report |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Executive Compensation Adjustment Policy |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Impact of Extended Patent Exclusivities on Product Access |
|
Shareholder |
|
Against |
|
For |
|
KONINKLIJKE PHILIPS N.V.
| Security |
500472303 |
Meeting Type |
Special |
| Ticker Symbol |
PHG |
Meeting Date |
30-Sep-2022 |
| Record Date |
02-Sep-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Proposal to appoint Mr R.W.O. Jakobs as President/Chief
Executive Officer and member of the Board of Management with effect from October 15, 2022. |
|
Management |
|
For |
|
|
|
KONINKLIJKE PHILIPS N.V.
| Security |
500472303 |
Meeting Type |
Annual |
| Ticker Symbol |
PHG |
Meeting Date |
09-May-2023 |
| Record Date |
11-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 2b. |
|
Annual Report 2022: Proposal to adopt the financial statements |
|
Management |
|
For |
|
|
|
| 2c. |
|
Annual Report 2022: Proposal to adopt dividend |
|
Management |
|
For |
|
|
|
| 2d. |
|
Annual Report 2022: Advisory vote on the Remuneration Report 2022 |
|
Management |
|
For |
|
|
|
| 2e. |
|
Annual Report 2022: Proposal to discharge the members of the Board of Management |
|
Management |
|
For |
|
|
|
| 2f. |
|
Annual Report 2022: Proposal to discharge the members of the Supervisory Board |
|
Management |
|
For |
|
|
|
| 3. |
|
Composition of the Board of Management: Proposal to re-appoint Mr A. Bhattacharya as member of the
Board of Management |
|
Management |
|
For |
|
|
|
| 4a. |
|
Composition of the Supervisory Board: Proposal to re- appoint Mr D.E.I. Pyott as member of the Supervisory
Board |
|
Management |
|
For |
|
|
|
| 4b. |
|
Composition of the Supervisory Board: Proposal to re- appoint Ms M.E. Doherty as member of the Supervisory
Board |
|
Management |
|
For |
|
|
|
| 5. |
|
Proposal to re-appoint Ernst & Young Accountants LLP as the company’s external auditor for
the financial year 2024 |
|
Management |
|
For |
|
|
|
| 6. |
|
Proposal to appoint PricewaterhouseCoopers Accountants N.V. as the company’s external auditor for
a term of four years starting the financial year 2025 |
|
Management |
|
For |
|
|
|
| 7a. |
|
Proposals to authorize the Board of Management to: issue shares or grant rights to acquire shares |
|
Management |
|
For |
|
|
|
| 7b. |
|
Proposals to authorize the Board of Management to: restrict or exclude pre-emption rights |
|
Management |
|
For |
|
|
|
| 8. |
|
Proposal to authorize the Board of Management to acquire shares in the company |
|
Management |
|
For |
|
|
|
| 9. |
|
Proposal to cancel shares |
|
Management |
|
For |
|
|
|
LABORATORY CORP. OF AMERICA HOLDINGS
| Security |
50540R409 |
Meeting Type |
Annual |
| Ticker Symbol |
LH |
Meeting Date |
11-May-2023 |
| Record Date |
16-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Kerrii B. Anderson |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Jean-Luc Bélingard |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Jeffrey A. Davis |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: D. Gary Gilliland, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kirsten M. Kliphouse |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Garheng Kong, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Peter M. Neupert |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Richelle P. Parham |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Adam H. Schechter |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Kathryn E. Wengel |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: R. Sanders Williams, M.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, by non-binding vote, executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To recommend by non-binding vote, the frequency of future non- binding votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings’
independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal relating to a policy regarding separation of the roles of Board Chairman and
Chief Executive Officer. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
Shareholder proposal regarding a Board report on transport of nonhuman primates within the U.S. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder proposal regarding a Board report on known risks of fulfilling information requests and
mitigation strategies. |
|
Shareholder |
|
Against |
|
For |
|
LTC PROPERTIES, INC.
| Security |
502175102 |
Meeting Type |
Annual |
| Ticker Symbol |
LTC |
Meeting Date |
24-May-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Cornelia Cheng |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Boyd W. Hendrickson |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to hold office until the 2024 Annual Meeting of Stockholders: James J. Pieczynski |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Devra G. Shapiro |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Wendy L. Simpson |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Timothy J. Triche |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency of the advisory vote on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
MALLINCKRODT PLC
| Security |
G5890A102 |
Meeting Type |
Annual |
| Ticker Symbol |
MNKPF |
Meeting Date |
29-Sep-2022 |
| Record Date |
10-Aug-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Paul M. Bisaro |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Daniel A. Celentano |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Riad H. El-Dada |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Neal P. Goldman |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Karen L. Ling |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Woodrow A. Myers, Jr., M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: James R. Sulat |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Sigurdur O. Olafsson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory non-binding vote to approve the re-appointment of the independent auditors and binding vote
to authorize the Audit Committee to set the independent auditors’ remuneration. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory non-binding vote to approve the Company’s executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Authorize the Company and/or any subsidiary of the Company to make market purchases or overseas market
purchases of Company shares. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Authorize the price range at which the Company can re- allot shares held as treasury shares (Special
Resolution). |
|
Management |
|
For |
|
For |
|
MALLINCKRODT PLC
| Security |
G5890A102 |
Meeting Type |
Annual |
| Ticker Symbol |
MNK |
Meeting Date |
16-May-2023 |
| Record Date |
20-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Paul M. Bisaro |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Daniel A. Celentano |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Riad H. El-Dada |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Neal P. Goldman |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Karen L. Ling |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Woodrow A. Myers, Jr., M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Susan M. Silbermann |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: James R. Sulat |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Sigurdur O. Olafsson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory non-binding vote to approve the re-appointment of the independent auditors and binding vote
to authorize the Audit Committee to set the independent auditors’ remuneration. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory non-binding vote to approve the Company’s executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Authorize the Company and/or any subsidiary of the Company to make market purchases or overseas market
purchases of Company shares. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Authorize the price range at which the Company can re- allot shares held as treasury shares (Special
Resolution). |
|
Management |
|
For |
|
For |
|
MCKESSON CORPORATION
| Security |
58155Q103 |
Meeting Type |
Annual |
| Ticker Symbol |
MCK |
Meeting Date |
22-Jul-2022 |
| Record Date |
27-May-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director for a one-year term: Richard H. Carmona, M.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director for a one-year term: Dominic J. Caruso |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director for a one-year term: W. Roy Dunbar |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director for a one-year term: James H. Hinton |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director for a one-year term: Donald R. Knauss |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director for a one-year term: Bradley E. Lerman |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director for a one-year term: Linda P. Mantia |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director for a one-year term: Maria Martinez |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director for a one-year term: Susan R. Salka |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director for a one-year term: Brian S. Tyler |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director for a one-year term: Kathleen Wilson- Thompson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Appointment of Deloitte & Touche LLP as the Company’s Independent Registered
Public Accounting Firm for Fiscal Year 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval of our 2022 Stock Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of Amendment to our 2000 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Shareholder Proposal on Special Shareholder Meeting Improvement. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder Proposal on Transparency in Rule 10b5-1 Trading Policy. |
|
Shareholder |
|
Against |
|
For |
|
MEDICAL PROPERTIES TRUST, INC.
| Security |
58463J304 |
Meeting Type |
Annual |
| Ticker Symbol |
MPW |
Meeting Date |
25-May-2023 |
| Record Date |
29-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Edward K. Aldag, Jr. |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: G. Steven Dawson |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: R. Steven Hamner |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: Caterina A. Mozingo |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: Emily W. Murphy |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Elizabeth N. Pitman |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: D. Paul Sparks, Jr. |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Michael G. Stewart |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director: C. Reynolds Thompson, III |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To recommend, on a non-binding, advisory basis, the frequency of future advisory votes on executive
compensation. |
|
Management |
|
1 Year |
|
For |
|
MEDTRONIC PLC
| Security |
G5960L103 |
Meeting Type |
Annual |
| Ticker Symbol |
MDT |
Meeting Date |
08-Dec-2022 |
| Record Date |
11-Oct-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Richard H. Anderson |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Craig Arnold |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Scott C. Donnelly |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Lidia L. Fonseca |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Andrea J. Goldsmith, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Randall J. Hogan, III |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Kevin E. Lofton |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Geoffrey S. Martha |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Elizabeth G. Nabel, M.D. |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Denise M. O’Leary |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director to hold office until the 2023 Annual General Meeting: Kendall J. Powell |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s
independent auditor for fiscal year 2023 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee,
to set the auditor’s remuneration. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approving, on an advisory basis, the Company’s executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Renewing the Board of Directors’ authority to issue shares under Irish law. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Renewing the Board of Directors’ authority to opt out of pre-emption rights under Irish law. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic
ordinary shares. |
|
Management |
|
For |
|
For |
|
MERCK & CO., INC.
| Security |
58933Y105 |
Meeting Type |
Annual |
| Ticker Symbol |
MRK |
Meeting Date |
23-May-2023 |
| Record Date |
24-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Douglas M. Baker, Jr. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Mary Ellen Coe |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Pamela J. Craig |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Robert M. Davis |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Thomas H. Glocer |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Risa J. Lavizzo-Mourey, M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Stephen L. Mayo, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Paul B. Rothman, M.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Patricia F. Russo |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Christine E. Seidman, M.D. |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Inge G. Thulin |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: Kathy J. Warden |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director: Peter C. Wendell |
|
Management |
|
For |
|
For |
|
| 2. |
|
Non-binding advisory vote to approve the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Non-binding advisory vote to approve the frequency of future votes to approve the compensation of
our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment of the Company’s independent registered public accounting firm for
2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal regarding business operations in China. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder proposal regarding access to COVID-19 products. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder proposal regarding indirect political spending. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder proposal regarding patents and access. |
|
Shareholder |
|
Against |
|
For |
|
| 9. |
|
Shareholder proposal regarding a congruency report of partnerships with globalist organizations. |
|
Shareholder |
|
Against |
|
For |
|
| 10. |
|
Shareholder proposal regarding an independent board chairman. |
|
Shareholder |
|
For |
|
Against |
|
MODERNA, INC.
| Security |
60770K107 |
Meeting Type |
Annual |
| Ticker Symbol |
MRNA |
Meeting Date |
03-May-2023 |
| Record Date |
08-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
Stephen Berenson |
|
|
|
For |
|
For |
|
| |
|
2 |
Sandra Horning, M.D. |
|
|
|
For |
|
For |
|
| |
|
3 |
Paul Sagan |
|
|
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding, advisory basis, the compensation of our named executive
officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the appointment of Ernst & Young LLP as our registered independent
public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To vote on a shareholder proposal requesting a report on transferring intellectual property. |
|
Shareholder |
|
Against |
|
For |
|
MOLINA HEALTHCARE, INC.
| Security |
60855R100 |
Meeting Type |
Annual |
| Ticker Symbol |
MOH |
Meeting Date |
03-May-2023 |
| Record Date |
08-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to hold office until the 2024 Annual Meeting: Barbara L. Brasier |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to hold office until the 2024 Annual Meeting: Daniel Cooperman |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to hold office until the 2024 Annual Meeting: Stephen H. Lockhart |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to hold office until the 2024 Annual Meeting: Steven J. Orlando |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to hold office until the 2024 Annual Meeting: Ronna E. Romney |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to hold office until the 2024 Annual Meeting: Richard M. Schapiro |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to hold office until the 2024 Annual Meeting: Dale B. Wolf |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to hold office until the 2024 Annual Meeting: Richard C. Zoretic |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to hold office until the 2024 Annual Meeting: Joseph M. Zubretsky |
|
Management |
|
For |
|
For |
|
| 2. |
|
To consider and approve, on a non-binding, advisory basis, the compensation of our named executive
officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To conduct an advisory vote on the frequency of a stockholder vote on the compensation of our named
executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting
firm for 2023. |
|
Management |
|
For |
|
For |
|
MORPHOSYS AG
| Security |
617760202 |
Meeting Type |
Annual |
| Ticker Symbol |
MOR |
Meeting Date |
17-May-2023 |
| Record Date |
07-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 2. |
|
Resolution on the approval of the actions of the members of the Management Board for the fiscal year
2022 |
|
Management |
|
For |
|
For |
|
| 3. |
|
Resolution on the approval of the actions of the members of the Supervisory Board for the fiscal
year 2022 |
|
Management |
|
For |
|
For |
|
| 4. |
|
Resolution on the election of the auditor for the financial year 2023 |
|
Management |
|
For |
|
For |
|
| 5a. |
|
Resolution on the election of member of the Supervisory Board: Individual Election of Mr. Michael
Brosnan |
|
Management |
|
For |
|
For |
|
| 5b. |
|
Resolution on the election of member of the Supervisory Board: Individual Election of Mr. George
Golumbeski, Ph.D. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Resolution on the cancellation of Authorized Capital 2021-I and the creation of a new Authorized
Capital 2023-I with the option to exclude statutory subscription rights; amendment to the Articles of Association |
|
Management |
|
For |
|
For |
|
| 7. |
|
Resolution on the cancellation of Authorized Capital 2021-II and the creation of a new Authorized
Capital 2023-II with the option to exclude statutory subscription rights; amendment to the Articles of Association |
|
Management |
|
For |
|
For |
|
| 8. |
|
Resolution on the reduction of the Conditional Capital 2016-III, on the reduction of the Authorized
Capital 2019-I as well as on the reduction of the Authorized Capital 2021-III; amendments to the Articles of Association |
|
Management |
|
For |
|
For |
|
| 9. |
|
Resolution on the approval of the Remuneration Report 2022 |
|
Management |
|
For |
|
For |
|
| 10a. |
|
Authorization to hold a virtual shareholders’ meeting |
|
Management |
|
For |
|
For |
|
| 10b. |
|
Virtual participation of Supervisory Board members in an Annual General Meeting |
|
Management |
|
For |
|
For |
|
NATIONAL HEALTH INVESTORS, INC.
| Security |
63633D104 |
Meeting Type |
Annual |
| Ticker Symbol |
NHI |
Meeting Date |
05-May-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: W. Andrew Adams |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Tracy M.J. Colden |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert A. McCabe, Jr. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approve the Amended and Restated 2019 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve the advisory resolution approving the compensation of the named executive officers as disclosed
in the accompanying Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approve the advisory vote on the frequency of the advisory vote on the compensation of the named
executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Ratify the audit committee’s selection of BDO USA, LLP as independent registered public accounting
firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
NOVARTIS AG
| Security |
66987V109 |
Meeting Type |
Annual |
| Ticker Symbol |
NVS |
Meeting Date |
07-Mar-2023 |
| Record Date |
24-Jan-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Approval of the Operating and Financial Review of Novartis AG, the Financial Statements of Novartis
AG and the Group Consolidated Financial Statements for the 2022 Financial Year |
|
Management |
|
For |
|
For |
|
| 2. |
|
Discharge from Liability of the Members of the Board of Directors and the Executive Committee |
|
Management |
|
For |
|
For |
|
| 3. |
|
Appropriation of Available Earnings of Novartis AG as per Balance Sheet and Declaration of Dividend
for 2022 |
|
Management |
|
For |
|
For |
|
| 4. |
|
Reduction of Share Capital |
|
Management |
|
For |
|
For |
|
| 5. |
|
Further Share Repurchases |
|
Management |
|
For |
|
For |
|
| 6A. |
|
Introduction of Article 12a of the Articles of Incorporation |
|
Management |
|
For |
|
For |
|
| 6B. |
|
Amendment of Articles 10, 14, 30, 33 and 34 of the Articles of Incorporation |
|
Management |
|
For |
|
For |
|
| 6C. |
|
Amendment of Articles 4-7, 9, 11-13, 16-18, 20-24, 27, 38 and 39 of the Articles of Incorporation |
|
Management |
|
For |
|
For |
|
| 7A. |
|
Binding Vote on the Maximum Aggregate Amount of Compensation for the Board of Directors from the
2023 Annual General Meeting to the 2024 Annual General Meeting |
|
Management |
|
For |
|
For |
|
| 7B. |
|
Binding Vote on the Maximum Aggregate Amount of Compensation for the Executive Committee for the
2024 Financial Year |
|
Management |
|
For |
|
For |
|
| 7C. |
|
Advisory Vote on the 2022 Compensation Report |
|
Management |
|
For |
|
For |
|
| 8A. |
|
Re-election of Joerg Reinhardt as Member and Board Chair |
|
Management |
|
For |
|
For |
|
| 8B. |
|
Re-election of Nancy C. Andrews |
|
Management |
|
For |
|
For |
|
| 8C. |
|
Re-election of Ton Buechner |
|
Management |
|
For |
|
For |
|
| 8D. |
|
Re-election of Patrice Bula |
|
Management |
|
For |
|
For |
|
| 8E. |
|
Re-election of Elizabeth Doherty |
|
Management |
|
For |
|
For |
|
| 8F. |
|
Re-election of Bridgette Heller |
|
Management |
|
For |
|
For |
|
| 8G. |
|
Re-election of Daniel Hochstrasser |
|
Management |
|
For |
|
For |
|
| 8H. |
|
Re-election of Frans van Houten |
|
Management |
|
For |
|
For |
|
| 8I. |
|
Re-election of Simon Moroney |
|
Management |
|
For |
|
For |
|
| 8J. |
|
Re-election of Ana de Pro Gonzalo |
|
Management |
|
For |
|
For |
|
| 8K. |
|
Re-election of Charles L. Sawyers |
|
Management |
|
For |
|
For |
|
| 8L. |
|
Re-election of William T. Winters |
|
Management |
|
For |
|
For |
|
| 8M. |
|
Election of John D. Young |
|
Management |
|
For |
|
For |
|
| 9A. |
|
Re-election of Patrice Bula |
|
Management |
|
For |
|
For |
|
| 9B. |
|
Re-election of Bridgette Heller |
|
Management |
|
For |
|
For |
|
| 9C. |
|
Re-election of Simon Moroney |
|
Management |
|
For |
|
For |
|
| 9D. |
|
Re-election of William T. Winters |
|
Management |
|
For |
|
For |
|
| 10. |
|
Re-election of the Auditor |
|
Management |
|
For |
|
For |
|
| 11. |
|
Re-election of the Independent Proxy |
|
Management |
|
For |
|
For |
|
| 12. |
|
General instructions in case of alternative motions under the agenda items published in the Notice
of Annual General Meeting, and/or of motions relating to additional agenda items according to Article 704b of the Swiss Code
of Obligations |
|
Management |
|
For |
|
For |
|
OCULIS HOLDING AG
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
8-Jul-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1 |
|
Change of Designation of the Existing Series C Preferred Shares and Revision of the Articles
of Association |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ordinary Share Capital Increase |
|
Management |
|
For |
|
For |
|
| 3. |
|
Conditional Share Capital Increase |
|
Management |
|
For |
|
For |
|
| 4. |
|
Election of Member to the Board of Directors |
|
Management |
|
For |
|
For |
|
OMEGA HEALTHCARE INVESTORS, INC.
| Security |
681936100 |
Meeting Type |
Annual |
| Ticker Symbol |
OHI |
Meeting Date |
05-Jun-2023 |
| Record Date |
06-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Kapila K. Anand |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Craig R. Callen |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Dr. Lisa C. Egbuonu-Davis |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Barbara B. Hill |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kevin J. Jacobs |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: C. Taylor Pickett |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Stephen D. Plavin |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Burke W. Whitman |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval, on an Advisory Basis, of Executive Compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory Vote on Frequency of Advisory Votes on Executive Compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Approval of Amendment to the Omega Healthcare Investors, Inc. 2018 Stock Incentive Plan to increase
the number of shares of Common Stock authorized for issuance thereunder. |
|
Management |
|
For |
|
For |
|
PERRIGO COMPANY PLC
| Security |
G97822103 |
Meeting Type |
Annual |
| Ticker Symbol |
PRGO |
Meeting Date |
04-May-2023 |
| Record Date |
06-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Bradley A. Alford |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Orlando D. Ashford |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Katherine C. Doyle |
|
Management |
|
For |
|
For |
|
| 1D. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Adriana Karaboutis |
|
Management |
|
For |
|
For |
|
| 1E. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Murray S. Kessler |
|
Management |
|
For |
|
For |
|
| 1F. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Jeffrey B. Kindler |
|
Management |
|
For |
|
For |
|
| 1G. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Erica L. Mann |
|
Management |
|
For |
|
For |
|
| 1H. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Albert A. Manzone |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Donal O’Connor |
|
Management |
|
For |
|
For |
|
| 1J. |
|
Election of Director to hold office until the 2024 Annual General Meeting: Geoffrey M. Parker |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company’s
independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration
of the auditor |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on executive compensation |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency of future advisory votes on executive compensation |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Renew the Board’s authority to issue shares under Irish law |
|
Management |
|
For |
|
For |
|
| 6. |
|
Renew the Board’s authority to opt-out of statutory pre- emption rights under Irish law |
|
Management |
|
For |
|
For |
|
| 7. |
|
Approve the creation of distributable reserves by reducing some or all of the Company’s share premium |
|
Management |
|
For |
|
For |
|
PFIZER INC.
| Security |
717081103 |
Meeting Type |
Annual |
| Ticker Symbol |
PFE |
Meeting Date |
27-Apr-2023 |
| Record Date |
01-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Ronald E. Blaylock |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Albert Bourla |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Susan Desmond-Hellmann |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Joseph J. Echevarria |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Scott Gottlieb |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Helen H. Hobbs |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Susan Hockfield |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Dan R. Littman |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Shantanu Narayen |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Suzanne Nora Johnson |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: James Quincey |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: James C. Smith |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify the selection of KPMG LLP as independent registered public accounting firm for 2023 |
|
Management |
|
For |
|
For |
|
| 3. |
|
2023 advisory approval of executive compensation |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on frequency of future advisory votes to approve executive compensation |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder proposal regarding ratification of termination pay |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder proposal regarding independent board chairman policy |
|
Shareholder |
|
For |
|
Against |
|
| 7. |
|
Shareholder proposal regarding transfer of intellectual property to potential COVID-19 manufacturers
feasibility report |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder proposal regarding impact of extended patent exclusivities on product access report |
|
Shareholder |
|
Against |
|
For |
|
| 9. |
|
Shareholder proposal regarding political contributions congruency report |
|
Shareholder |
|
Against |
|
For |
|
PHYSICIANS REALTY TRUST
| Security |
71943U104 |
Meeting Type |
Annual |
| Ticker Symbol |
DOC |
Meeting Date |
03-May-2023 |
| Record Date |
24-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Trustee: John T. Thomas |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Trustee: Tommy G. Thompson |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Trustee: Stanton D. Anderson |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Trustee: Mark A. Baumgartner |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Trustee: Albert C. Black, Jr. |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Trustee: William A. Ebinger, M.D. |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Trustee: Pamela J. Kessler |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Trustee: Ava E. Lias-Booker |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Trustee: Richard A. Weiss |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public
accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve the Amended and Restated Physicians Realty Trust 2013 Equity Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
To approve the Amended and Restated Physicians Realty Trust 2015 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
PRIOTHERA LIMITED
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
5-Dec-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Notice of Appointment of Authorized Person |
|
Management |
|
For |
|
For |
|
R1 RCM INC.
| Security |
77634L105 |
Meeting Type |
Annual |
| Ticker Symbol |
RCM |
Meeting Date |
17-May-2023 |
| Record Date |
21-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
B. Kyle Armbrester |
|
|
|
For |
|
For |
|
| |
|
2 |
Agnes Bundy Scanlan |
|
|
|
For |
|
For |
|
| |
|
3 |
Brian K. Dean |
|
|
|
For |
|
For |
|
| |
|
4 |
Jeremy Delinsky |
|
|
|
For |
|
For |
|
| |
|
5 |
David M. Dill |
|
|
|
For |
|
For |
|
| |
|
6 |
Michael C. Feiner |
|
|
|
For |
|
For |
|
| |
|
7 |
Joseph Flanagan |
|
|
|
For |
|
For |
|
| |
|
8 |
John B. Henneman III |
|
|
|
For |
|
For |
|
| |
|
9 |
Matthew Holt |
|
|
|
For |
|
For |
|
| |
|
10 |
Neal Moszkowski |
|
|
|
For |
|
For |
|
| |
|
11 |
Lee Rivas |
|
|
|
For |
|
For |
|
| |
|
12 |
Ian Sacks |
|
|
|
For |
|
For |
|
| |
|
13 |
Jill Smith |
|
|
|
For |
|
For |
|
| |
|
14 |
Anthony J. Speranzo |
|
|
|
For |
|
For |
|
| |
|
15 |
Anthony R. Tersigni |
|
|
|
For |
|
For |
|
| |
|
16 |
Janie Wade |
|
|
|
For |
|
For |
|
| 2. |
|
To approve our Fourth Amended and Restated 2010 Stock Incentive Plan to increase the
number of shares authorized for issuance under our Third Amended and Restated 2010 Stock Incentive Plan by 4 million shares. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on an advisory basis, the frequency of advisory stockholder votes on the
compensation of our Named Executive Officers. |
|
Management |
|
1 Year |
|
Against |
|
| 4. |
|
To ratify the selection of Ernst & Young LLP as our independent registered public
accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
REGENERON PHARMACEUTICALS, INC.
| Security |
75886F107 |
Meeting Type |
Annual |
| Ticker Symbol |
REGN |
Meeting Date |
09-Jun-2023 |
| Record Date |
11-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Joseph L. Goldstein, M.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Christine A. Poon |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Craig B. Thompson, M.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Huda Y. Zoghbi, M.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Proposal to approve, on an advisory basis, executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Proposal to approve, on an advisory basis, the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Non-binding shareholder proposal, if properly presented, requesting report on a process by which
access to medicine is considered in matters related to protecting intellectual property. |
|
Shareholder |
|
Against |
|
For |
|
RESMED INC.
| Security |
761152107 |
Meeting Type |
Annual |
| Ticker Symbol |
RMD |
Meeting Date |
16-Nov-2022 |
| Record Date |
20-Sep-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to serve until our 2023 annual meeting: Carol Burt |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to serve until our 2023 annual meeting: Jan De Witte |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to serve until our 2023 annual meeting: Karen Drexler |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to serve until our 2023 annual meeting: Michael Farrell |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to serve until our 2023 annual meeting: Peter Farrell |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to serve until our 2023 annual meeting: Harjit Gill |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to serve until our 2023 annual meeting: John Hernandez |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to serve until our 2023 annual meeting: Richard Sulpizio |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to serve until our 2023 annual meeting: Desney Tan |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to serve until our 2023 annual meeting: Ronald Taylor |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal
year ending June 30, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed
in the proxy statement (“say-on-pay”). |
|
Management |
|
For |
|
For |
|
SABRA HEALTH CARE REIT, INC.
| Security |
78573L106 |
Meeting Type |
Annual |
| Ticker Symbol |
SBRA |
Meeting Date |
14-Jun-2023 |
| Record Date |
18-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Craig A. Barbarosh |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Katie Cusack |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Michael J. Foster |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Lynne S. Katzmann |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Ann Kono |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Jeffrey A. Malehorn |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Richard K. Matros |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Clifton J. Porter II |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra’s independent registered public
accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval, on an advisory basis, of the compensation of Sabra’s named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
SANOFI
| Security |
80105N105 |
Meeting Type |
Annual |
| Ticker Symbol |
SNY |
Meeting Date |
25-May-2023 |
| Record Date |
05-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Approval of the individual company financial statements for the year ended December 31, 2022 |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval of the consolidated financial statements for the year ended December 31, 2022 |
|
Management |
|
For |
|
For |
|
| 3. |
|
Appropriation of profits for the year ended December 31, 2022 and declaration of dividend |
|
Management |
|
For |
|
For |
|
| 4. |
|
Appointment of Frédéric Oudéa as a director |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of the report on the compensation of corporate officers issued in accordance with Article L.
22-10-9 of the French Commercial Code |
|
Management |
|
For |
|
For |
|
| 6. |
|
Approval of the components of the compensation paid or awarded in respect of the year ended December 31,
2022 to Serge Weinberg, Chairman of the Board |
|
Management |
|
For |
|
For |
|
| 7. |
|
Approval of the components of the compensation paid or awarded in respect of the year ended December 31,
2022 to Paul Hudson, Chief Executive Officer |
|
Management |
|
For |
|
For |
|
| 8. |
|
Setting the compensation for directors |
|
Management |
|
For |
|
For |
|
| 9. |
|
Approval of the compensation policy for directors |
|
Management |
|
For |
|
For |
|
| 10. |
|
Approval of the compensation policy for the Chairman of the Board of Directors |
|
Management |
|
For |
|
For |
|
| 11. |
|
Approval of the compensation policy for the Chief Executive Officer |
|
Management |
|
For |
|
For |
|
| 12. |
|
Reappointment of Pricewaterhouse Coopers Audit as a statutory auditor |
|
Management |
|
For |
|
For |
|
| 13. |
|
Ratification of the transfer of the registered office (ratification of the decision of the Board
of Directors to ...(due to space limits, see proxy material for full proposal). |
|
Management |
|
For |
|
For |
|
| 14. |
|
Authorization to the Board of Directors to carry out transactions in the Company’s shares (usable
outside the period of a public tender offer) |
|
Management |
|
For |
|
For |
|
| 15. |
|
Authorization to the Board of Directors to reduce the share capital by cancellation of treasury shares |
|
Management |
|
For |
|
For |
|
| 16. |
|
Delegation to the Board of Directors of competence to decide to issue, with shareholders’ preemptive
rights maintained, shares ...(due to space limits, see proxy material for full proposal). |
|
Management |
|
For |
|
For |
|
| 17. |
|
Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 18. |
|
Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 19. |
|
Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 20. |
|
Delegation to the Board of Directors of competence to increase ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 21. |
|
Delegation to the Board of Directors of competence with a view ...(due to space limits, see proxy
material for full proposal). |
|
Management |
|
For |
|
For |
|
| 22. |
|
Delegation to the Board of Directors of competence to decide to carry out increases in the share
capital by incorporation of share premium, reserves, profits or other items (usable outside the period of a public tender offer) |
|
Management |
|
For |
|
For |
|
| 23. |
|
Delegation to the Board of Directors of competence to decide on the issuance of shares or securities
giving access to the Company’s share capital reserved for members of savings plans, with waiver of preemptive rights in their favor. |
|
Management |
|
For |
|
For |
|
| 24. |
|
Powers to carry out formalities (Ordinary & Extraordinary Business) |
|
Management |
|
For |
|
For |
|
SMITH & NEPHEW PLC
| Security |
83175M205 |
Meeting Type |
Annual |
| Ticker Symbol |
SNN |
Meeting Date |
26-Apr-2023 |
| Record Date |
21-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To receive the audited accounts for the financial year ended 31 December 2022. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve the Directors’ Remuneration Policy. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve the Directors’ Remuneration Report. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To declare a final dividend. |
|
Management |
|
For |
|
For |
|
| 5. |
|
ELECTION OF DIRECTOR: Rupert Soames OBE |
|
Management |
|
For |
|
For |
|
| 6. |
|
ELECTION OF DIRECTOR: Erik Engstrom |
|
Management |
|
For |
|
For |
|
| 7. |
|
ELECTION OF DIRECTOR: Jo Hallas |
|
Management |
|
For |
|
For |
|
| 8. |
|
ELECTION OF DIRECTOR: John Ma |
|
Management |
|
For |
|
For |
|
| 9. |
|
ELECTION OF DIRECTOR: Katarzyna Mazur-Hofsaess |
|
Management |
|
For |
|
For |
|
| 10. |
|
ELECTION OF DIRECTOR: Rick Medlock |
|
Management |
|
For |
|
For |
|
| 11. |
|
ELECTION OF DIRECTOR: Deepak Nath |
|
Management |
|
For |
|
For |
|
| 12. |
|
ELECTION OF DIRECTOR: Anne-Françoise Nesmes |
|
Management |
|
For |
|
For |
|
| 13. |
|
ELECTION OF DIRECTOR: Marc Owen |
|
Management |
|
For |
|
For |
|
| 14. |
|
ELECTION OF DIRECTOR: Roberto Quarta |
|
Management |
|
For |
|
For |
|
| 15. |
|
ELECTION OF DIRECTOR: Angie Risley |
|
Management |
|
For |
|
For |
|
| 16. |
|
ELECTION OF DIRECTOR: Bob White |
|
Management |
|
For |
|
For |
|
| 17. |
|
To re-appoint KPMG LLP as the Auditor. |
|
Management |
|
For |
|
For |
|
| 18. |
|
To authorise the Directors to determine the remuneration of the Auditor. |
|
Management |
|
For |
|
For |
|
| 19. |
|
To renew the authorisation of the Directors to allot shares. |
|
Management |
|
For |
|
For |
|
| 20. |
|
Directors given power to allot equity securities in the Company for cash through the sale of treasury
shares. |
|
Management |
|
For |
|
For |
|
| 21. |
|
Directors given power to allot equity securities in the Company for cash through the sale of ordinary
shares held by the Company as treasury shares. |
|
Management |
|
For |
|
For |
|
| 22. |
|
That the Company be generally and unconditionally authorised to make market purchases of the Company’s
own shares. |
|
Management |
|
For |
|
For |
|
| 23. |
|
To authorise general meetings to be held on 14 clear days’ notice. |
|
Management |
|
For |
|
For |
|
STRYKER CORPORATION
| Security |
863667101 |
Meeting Type |
Annual |
| Ticker Symbol |
SYK |
Meeting Date |
10-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Mary K. Brainerd |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Giovanni Caforio, M.D. |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Srikant M. Datar, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Allan C. Golston |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President) |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Sherilyn S. McCoy (Lead Independent Director) |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Andrew K. Silvernail |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Lisa M. Skeete Tatum |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Ronda E. Stryker |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Rajeev Suri |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting
Firm for 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote to Approve Named Executive Officer Compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder Proposal on Political Disclosure. |
|
Shareholder |
|
Against |
|
For |
|
TAKEDA PHARMACEUTICAL CO LTD
| Security |
874060205 |
Meeting Type |
Annual |
| Ticker Symbol |
TAK |
Meeting Date |
28-Jun-2023 |
| Record Date |
31-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Appropriation of Surplus |
|
Management |
|
For |
|
For |
|
| 2a. |
|
Election of Director who are not Audit and Supervisory Committee Member: Christophe Weber |
|
Management |
|
For |
|
For |
|
| 2b. |
|
Election of Director who are not Audit and Supervisory Committee Member: Andrew Plump |
|
Management |
|
For |
|
For |
|
| 2c. |
|
Election of Director who are not Audit and Supervisory Committee Member: Costa Saroukos |
|
Management |
|
For |
|
For |
|
| 2d. |
|
Election of Director who are not Audit and Supervisory Committee Member: Masami Iijima |
|
Management |
|
For |
|
For |
|
| 2e. |
|
Election of Director who are not Audit and Supervisory Committee Member: Olivier Bohuon |
|
Management |
|
For |
|
For |
|
| 2f. |
|
Election of Director who are not Audit and Supervisory Committee Member: Jean-Luc Butel |
|
Management |
|
For |
|
For |
|
| 2g. |
|
Election of Director who are not Audit and Supervisory Committee Member: Ian Clark |
|
Management |
|
For |
|
For |
|
| 2h. |
|
Election of Director who are not Audit and Supervisory Committee Member: Steven Gillis |
|
Management |
|
For |
|
For |
|
| 2i. |
|
Election of Director who are not Audit and Supervisory Committee Member: John Maraganore |
|
Management |
|
For |
|
For |
|
| 2j. |
|
Election of Director who are not Audit and Supervisory Committee Member: Michel Orsinger |
|
Management |
|
For |
|
For |
|
| 2k. |
|
Election of Director who are not Audit and Supervisory Committee Member: Miki Tsusaka |
|
Management |
|
For |
|
For |
|
| 3. |
|
Payment of Bonuses to Directors who are not Audit and Supervisory Committee Members |
|
Management |
|
For |
|
For |
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
| Security |
881624209 |
Meeting Type |
Annual |
| Ticker Symbol |
TEVA |
Meeting Date |
15-Jun-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director: Dr. Sol J. Barer |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director: M. Braverman-Blumenstyk |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director: Janet S. Vergis |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding advisory basis, the compensation for Teva’s named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd.,
as Teva’s independent registered public accounting firm until Teva’s 2024 annual meeting of shareholders. |
|
Management |
|
For |
|
For |
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
| Security |
881624209 |
Meeting Type |
Annual |
| Ticker Symbol |
TEVA |
Meeting Date |
15-Jun-2023 |
| Record Date |
08-May-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director: Dr. Sol J. Barer |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director: M. Braverman-Blumenstyk |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director: Janet S. Vergis |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding advisory basis, the compensation for Teva’s named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd.,
as Teva’s independent registered public accounting firm until Teva’s 2024 annual meeting of shareholders. |
|
Management |
|
For |
|
For |
|
THE CIGNA GROUP
| Security |
125523100 |
Meeting Type |
Annual |
| Ticker Symbol |
CI |
Meeting Date |
26-Apr-2023 |
| Record Date |
07-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: David M. Cordani |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: William J. DeLaney |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Eric J. Foss |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Retired Maj. Gen. Elder Granger, M.D. |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Neesha Hathi |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: George Kurian |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Kathleen M. Mazzarella |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Mark B. McClellan, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Kimberly A. Ross |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Eric C. Wiseman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Donna F. Zarcone |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory approval of The Cigna Group’s executive compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory approval of the frequency of future advisory votes on executive compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered
public accounting firm for 2023 |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain
officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law |
|
Management |
|
For |
|
For |
|
| 6. |
|
Shareholder proposal - Special shareholder meeting improvement |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder proposal - Political contributions report |
|
Shareholder |
|
Against |
|
For |
|
THERMO FISHER SCIENTIFIC INC.
| Security |
883556102 |
Meeting Type |
Annual |
| Ticker Symbol |
TMO |
Meeting Date |
24-May-2023 |
| Record Date |
27-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Marc N. Casper |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Nelson J. Chai |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Ruby R. Chandy |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: C. Martin Harris |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Tyler Jacks |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: R. Alexandra Keith |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: James C. Mullen |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Lars R. Sørensen |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Debora L. Spar |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Scott M. Sperling |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Dion J. Weisler |
|
Management |
|
For |
|
For |
|
| 2. |
|
An advisory vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
An advisory vote on the frequency of future named executive officer advisory votes. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the Audit Committee’s selection of PricewaterhouseCoopers LLP as the Company’s independent
auditors for 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of the Company’s Amended and Restated 2013 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Approval of the Company’s 2023 Global Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
UNITEDHEALTH GROUP INCORPORATED
| Security |
91324P102 |
Meeting Type |
Annual |
| Ticker Symbol |
UNH |
Meeting Date |
05-Jun-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Timothy Flynn |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Paul Garcia |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Kristen Gil |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Stephen Hemsley |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Michele Hooper |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: F. William McNabb III |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Valerie Montgomery Rice, M.D. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: John Noseworthy, M.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Andrew Witty |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory approval of the Company’s executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory approval of the frequency of holding future say- on-pay votes. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment of Deloitte & Touche LLP as the independent registered public
accounting firm for the Company for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking
a third- party racial equity audit. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal requiring
a political contributions congruency report. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking
shareholder ratification of termination pay. |
|
Shareholder |
|
Against |
|
For |
|
UNIVERSAL HEALTH REALTY INCOME TRUST
| Security |
91359E105 |
Meeting Type |
Annual |
| Ticker Symbol |
UHT |
Meeting Date |
07-Jun-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Trustee: Alan B. Miller |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Trustee: Robert F. McCadden |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory (nonbinding) vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory (nonbinding) vote on the frequency of future advisory shareholder votes to approve named
executive officer compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Proposal to ratify the selection of KPMG, LLP as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
VENTAS, INC.
| Security |
92276F100 |
Meeting Type |
Annual |
| Ticker Symbol |
VTR |
Meeting Date |
16-May-2023 |
| Record Date |
24-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Melody C. Barnes |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Debra A. Cafaro |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Michael J. Embler |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Matthew J. Lustig |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Roxanne M. Martino |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Marguerite M. Nader |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Sean P. Nolan |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Walter C. Rakowich |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Sumit Roy |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: James D. Shelton |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Maurice S. Smith |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval, on an advisory basis, of the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve, on an advisory basis, the frequency of advisory votes on the compensation of our named executive
officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the selection of KPMG LLP as our independent registered public accounting firm for
fiscal year 2023. |
|
Management |
|
For |
|
For |
|
VERTEX PHARMACEUTICALS INCORPORATED
| Security |
92532F100 |
Meeting Type |
Annual |
| Ticker Symbol |
VRTX |
Meeting Date |
17-May-2023 |
| Record Date |
23-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Sangeeta Bhatia |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Lloyd Carney |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Alan Garber |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: Terrence Kearney |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: Reshma Kewalramani |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Jeffrey Leiden |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: Diana McKenzie |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Bruce Sachs |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director: Suketu Upadhyay |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the
year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote to approve named executive office compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
WELLTOWER INC.
| Security |
95040Q104 |
Meeting Type |
Annual |
| Ticker Symbol |
WELL |
Meeting Date |
23-May-2023 |
| Record Date |
03-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Kenneth J. Bacon |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Karen B. DeSalvo |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Philip L. Hawkins |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Dennis G. Lopez |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Shankh Mitra |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Ade J. Patton |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Diana W. Reid |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Sergio D. Rivera |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Johnese M. Spisso |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Kathryn M. Sullivan |
|
Management |
|
For |
|
For |
|
| 2. |
|
The ratification of the appointment of Ernst & Young LLP as independent registered public
accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
The approval, on an advisory basis, of the compensation of our named executive officers as disclosed
in the 2023 Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
An advisory vote on the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
WEST PHARMACEUTICAL SERVICES, INC.
| Security |
955306105 |
Meeting Type |
Annual |
| Ticker Symbol |
WST |
Meeting Date |
25-Apr-2023 |
| Record Date |
03-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Mark A. Buthman |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: William F. Feehery |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert F. Friel |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Eric M. Green |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Thomas W. Hofmann |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Molly E. Joseph |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Deborah L. V. Keller |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Myla P. Lai-Goldman |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Stephen H. Lockhart |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Douglas A. Michels |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Paolo Pucci |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting
firm for 2023. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency of an advisory vote on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder proposal regarding Fair Elections. |
|
Shareholder |
|
For |
|
Against |
|
ZIMMER BIOMET HOLDINGS, INC.
| Security |
98956P102 |
Meeting Type |
Annual |
| Ticker Symbol |
ZBH |
Meeting Date |
12-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Christopher B. Begley |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Betsy J. Bernard |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Michael J. Farrell |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Robert A. Hagemann |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Bryan C. Hanson |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Arthur J. Higgins |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Maria Teresa Hilado |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Syed Jafry |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Sreelakshmi Kolli |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Michael W. Michelson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting
firm for 2023 |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve, on a non-binding advisory basis, named executive officer compensation (“Say on Pay”) |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approve, on a non-binding advisory basis, the frequency of future Say on Pay votes |
|
Management |
|
1 Year |
|
For |
|
ZOETIS INC.
| Security |
98978V103 |
Meeting Type |
Annual |
| Ticker Symbol |
ZTS |
Meeting Date |
18-May-2023 |
| Record Date |
24-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Paul M. Bisaro |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Vanessa Broadhurst |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Frank A. D’Amelio |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Michael B. McCallister |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Gregory Norden |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Louise M. Parent |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Kristin C. Peck |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Robert W. Scully |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve our executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Ratification of appointment of KPMG LLP as our independent registered public accounting firm for
2023. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval of an amendment to our Restated Certificate of Incorporation to create a right to call a
special meeting. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal regarding ability to call a special meeting. |
|
Shareholder |
|
Against |
|
For |
|
SIGNATURES
Pursuant to the requirements of the Investment
Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| (Registrant) |
Tekla
World Healthcare Fund |
| |
|
| By (Signature and Title)* |
|
| |
/s/ Daniel R.
Omstead |
| |
(Daniel R. Omstead, President) |
| |
|
| Date |
8/4/23 |
| |
|
|
|
*Print the name and title of each signing officer under his or her
signature.
abrdn World Healthcare (NYSE:THW)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
abrdn World Healthcare (NYSE:THW)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
